Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Results reported from first-in-human trial of hepatitis C therapeutic ABT-072

Jan. 11, 2010

Hepatitis C therapeutic filibuvir safe and well tolerated in phase I-II studies

Jan. 11, 2010

INCB-7839 improves response to trastuzumab in metastatic HER2+ breast cancer

Jan. 7, 2010

8-Chloro-adenosine to be investigated in patients with breast cancer

Jan. 5, 2010

Data reported from three phase II studies of BIBW-2992 in metastatic breast cancer

Jan. 5, 2010

Millennium's TAK-285 may have potential to treat brain metastases from breast cancer

Jan. 4, 2010

IGF-I receptor inhibitor PQIP enhances doxorubicin cytotoxicity in human cancer cell lines

Jan. 4, 2010

Recommended phase I dose of breast cancer candidate SR-16157 determined

Jan. 4, 2010

Preclinical studies reveal potential of KX-01 for treatment of breast cancer

Jan. 4, 2010

Phase I results suggest ARRY-380 is well tolerated, active in breast cancer patients

Dec. 31, 2009

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...